pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

19 catalysts · 10 phase 2 completion · 3 phase 2 initiation · 2 phase 1 results · 1 phase iv trial initiation · 1 phase 2 3 completion · 1 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 11 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
TA: nsclc×TA: womens-health×clear all
type
  • phase 2 completion10
  • phase 2 initiation3
  • phase 1 results2
  • phase iv trial initiation1
  • phase 2 3 completion1
  • phase 1 completion1
phase 0 trial completion
1
therapy area
  • Oncology148
  • Infectious Disease46
  • Cardiology37
  • Immunology35
  • Dermatology31
  • Pulmonology22
  • Women's Health19
  • Ophthalmology16
  • Pain15

Week of Apr 20, 2026

8
›Apr 24, 2026phase 1 results91d agoMedicus Pharma Ltd — teverelix (Phase I Trial Results)teverelix

Therapy area: Women's Health. Indication: Endometriosis

full page →teverelix →source: globaldata
›Apr 24, 2026phase 1 results91d agoMedicus Pharma Ltd — teverelix (Phase I Trial Results)teverelix

Therapy area: Women's Health. Indication: Endometriosis

full page →teverelix →source: globaldata
›Apr 24, 2026phase iv trial initiation91d agoIxoreal Biomed Pvt Ltd — shatavari (Phase IV Trial Initiation)shatavari

Therapy area: Hormonal Disorders, Women's Health. Indication: Menstrual Disorders, Unspecified Hormonal Disorders

full page →shatavari →source: globaldata
›Apr 25, 2026phase 2 initiation90d agoAffiliated Renhe Hospital of China Three Gorges University — platelet rich plasma (Phase II Trial Initiation)platelet rich plasma

Therapy area: Women's Health. Indication: Unspecified Gynecological Disorders

full page →platelet rich plasma →source: globaldata
›Apr 26, 2026phase 2 completion89d agoBanaras Hindu University — oxytocin (Phase II Trial Completion)Oxytocin Hikma

Therapy area: Women's Health. Indication: Unspecified Gynecological Disorders

full page →Oxytocin Hikma →source: globaldata
›Apr 26, 2026phase 2 completion89d agoBangalore Medical College and Research Institute — bupivacaine (Phase II Trial Completion)bupivacaine

Therapy area: Infectious Disease, Women's Health. Indication: Labor And Delivery, Pregnancy, Puerperal Infection

full page →bupivacaine →source: globaldata
›Apr 26, 2026phase 2 initiation89d agoTianFang Pharmaceutical Co — diclofenac sodium DR (Phase II Trial Initiation)DICLOFENAC SODIUM

Therapy area: Central Nervous System, Immunology, Musculoskeletal Disorders, Other Diseases, Women's Health. Indication: Dental Pain (Toothache/Tooth Pain), Dysmenorrhea, Gouty Arthritis (Gout), Injury, Myalgia (Muscle Pain), Osteoarthritis, Pain, Post-Operative Pain, Rheumatic Disorders, Rheumatoid Arthritis, Spondyloarthritis (Spondyloarthropathy), Tenosynovitis

full page →DICLOFENAC SODIUM →source: globaldata
›Apr 26, 2026phase 2 3 completion89d agoAll India Institute of Medical Sciences — progesterone (Phase II/III Trial Completion)PROGESTERONE

Therapy area: Women's Health. Indication: Female Infertility

full page →PROGESTERONE →source: globaldata

Week of Apr 27, 2026

11
›Apr 27, 2026phase 2 initiation88d agoYichun Maternal and Child health Care Hospital — sufentanil (Phase II Trial Initiation)sufentanil

Therapy area: Central Nervous System, Women's Health. Indication: Labor And Delivery, Pain

full page →sufentanil →source: globaldata
›Apr 28, 2026phase 2 completion
87d ago
Ardabil University of Medical Sciences — chorionic gonadotropin (Phase II Trial Completion)chorionic gonadotropin

Therapy area: Women's Health. Indication: Female Infertility

full page →chorionic gonadotropin →source: globaldata
›Apr 29, 2026phase 2 completion86d agoNational Institute of Unani Medicine — unani medicine (Phase II Trial Completion)unani medicine

Therapy area: Women's Health. Indication: Menorrhagia

full page →unani medicine →source: globaldata
›Apr 30, 2026phase 0 trial completion85d agoSecond Affiliated Hospital of Anhui Medical University — yingtao shujie paste (Phase 0 Trial Completion)yingtao shujie paste

Therapy area: Oncology, Women's Health. Indication: Breast Cancer, Breast Hyperplasia

full page →yingtao shujie paste →source: globaldata
›Apr 30, 2026phase 1 completion85d agoEcolab Inc — (acetaminophen + ibuprofen) (Phase I Trial Completion)(acetaminophen + ibuprofen)

Therapy area: Central Nervous System, Ear Nose Throat Disorders, Hormonal Disorders, Immunology, Musculoskeletal Disorders, Other Diseases, Women's Health. Indication: Ankylosing Spondylitis (Bekhterev's Disease), Dental Pain (Toothache/Tooth Pain), Fever, Fibromyalgia (Fibromyalgia Syndrome), Gouty Arthritis (Gout), Hyperthyroidism, Laryngitis, Low Back Pain, Mixed Pain (Nociceptive Pain/Neuropathic Pain), Musculoskeletal Inflammation, Musculoskeletal Pain, Myalgia (Muscle Pain), Neuropathic Pa

full page →(acetaminophen + ibuprofen) →source: globaldata
›Apr 30, 2026phase 2 completion85d agoUniversity of Benin Teaching Hospital — doxycycline (Phase II Trial Completion)doxycycline ER

Therapy area: Women's Health. Indication: Unspecified Gynecological Disorders

full page →doxycycline ER →source: globaldata
›Apr 30, 2026phase 2 completion85d agoNational Health and Medical Research Council — docosahexaenoic acid (Phase II Trial Completion)docosahexaenoic acid

Therapy area: Women's Health. Indication: Labor And Delivery

full page →docosahexaenoic acid →source: globaldata
›Apr 30, 2026phase 2 completion85d agoTaian City Central Hospital — alfentanil (Phase II Trial Completion)alfentanil

Therapy area: Women's Health. Indication: Unspecified Gynecological Disorders

full page →alfentanil →source: globaldata
›Apr 30, 2026phase 2 completion85d agoCentrum Clinic IVF Center — follitropin (Phase II Trial Completion)follitropin

Therapy area: Women's Health. Indication: Female Infertility

full page →follitropin →source: globaldata
›Apr 30, 2026phase 2 completion85d agoFirst Affiliated Hospital of Kunming Medical University — sugammadex (Phase II Trial Completion)sugammadex

Therapy area: Non Malignant Disorders, Women's Health. Indication: Unspecified Gynecological Disorders, Uterine Leiomyoma (Uterine Fibroids)

full page →sugammadex →source: globaldata
›Apr 30, 2026phase 2 completion85d agoPolice General Hospital — acetaminophen (Phase II Trial Completion)acetaminophen ER

Therapy area: Central Nervous System, Women's Health. Indication: Labor And Delivery, Pain

full page →acetaminophen ER →source: globaldata
$MDCX0.3755+0.27%
$MDCX0.3755+0.27%
$ECL266.88+1.01%